Iatrogenic damage in the neonatal period

Seminars in Neonatology : SN
Peter G J Nikkels

Abstract

Iatrogenic damage from a therapeutic procedure in the neonatal period can have serious consequences. Although most side effects are minor, some may result in a major handicap or death of the infant. The development of new therapeutic strategies may result in not previously observed combinations of pathology. This review focuses on iatrogenic damage occurring in several organs and after several different therapeutic interventions. Special attention is given to pulmonary and gastrointestinal damage and iatrogenic damage as a result of systemic treatments. Valuable information and early detection of serious side effects is only possible when the pathologist is very well informed about the therapeutic interventions used, all medical devices are left in situ and a thorough autopsy is performed as completely as is permitted. However, the decline in autopsy rates could make it more difficult to determine the incidence of iatrogenic lesions.

References

Feb 1, 1978·The American Journal of Nursing·L Borgen
Feb 1, 1992·British Journal of Obstetrics and Gynaecology·J G van der PolA Vos
Jan 1, 1987·Pediatric Pathology·S HeffelfingerC Langston
Jan 1, 1985·European Journal of Pediatrics·G KühlH W Seyberth
Jan 1, 1971·The Journal of Pediatrics·V H PedenM A Skelton
Jan 1, 1981·Virchows Archiv. A, Pathological Anatomy and Histology·J W Keeling
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·E A PierceL E Smith
Jun 1, 1997·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·T L YoungL E Smith
Nov 22, 2000·Archives of Disease in Childhood·L M RossJ Y Paton
Jan 6, 2001·American Journal of Perinatology·J TermoteB P Cats
Jan 11, 2001·The New England Journal of Medicine·A R StarkUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
Apr 11, 2001·Neurology·A HamadS Momeni
Jun 18, 2002·American Journal of Obstetrics and Gynecology·Ronald J WapnerLaird G Jackson
Nov 20, 2002·Pediatric Research·Willem B de VriesFrank van Bel
Apr 2, 2003·Seminars in Neonatology : SN·David G Grier, Henry L Halliday
Jun 5, 2003·JAMA : the Journal of the American Medical Association·Kaveh G ShojaniaLee Goldman

❮ Previous
Next ❯

Citations

Sep 14, 2011·Neonatology·Leah HickeyTom Clarke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.